There are two main kinds of antidepressive* compounds - monoamineoxidase (MAO) inhibitors and iminodibenzyl (tricyclic) derivatives. At present the number of the latter is still increasing, though there has been no new MAO inhibitor for five years. There are now eight different ‘tricyclic’ compounds available as thirteen different products; is there a need for yet another?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.